Evgen encouraged by trials progress
12th December 2018
Drug discovery group Evgen Pharma said it is pleased with its progress on treatments under development. The business focuses on treatments for cancer, strokes and...
Seneca EIS Portfolio Service
Specialising in the provision of growth capital and strategic support to ambitious SME’s...
Learn moreInvestment size
Typically £500k+
Sectors of interest
We are sector agnostic, investing equity across a wide range of sectors
Investment timelines
We are fast to transact and look for exits between 3 and 5 years
Who are the Seneca EIS Investment team…
Our team is responsible for investing EIS funds into growing businesses, on behalf of our underlying investors.
Collectively, our team has a wealth of advisory, investment experience and pedigree combined with a truly entrepreneurial culture.
We also leverage knowledge and strategic advice from our Unique Advisory Network of in excess of 300 High Net Worths and seasoned entrepreneurs.
Learn more41
investee companies
£48
million invested
74
investment rounds